Suppr超能文献

经皮瓣膜介入治疗的进展

Advances in percutaneous valvular intervention.

作者信息

Casserly Ivan P, Kapadia Samir R

机构信息

Director of Cardiovascular Intervention, Denver VA Medical Center, Department of Cardiology, 1055 Clermont Street, Denver, CO 80220, USA.

出版信息

Expert Rev Cardiovasc Ther. 2005 Jan;3(1):143-58. doi: 10.1586/14779072.3.1.143.

Abstract

We are entering a new era in the percutaneous treatment of valvular heart disease. Novel techniques and devices have given rise to the possible treatment of a range of valvular heart diseases that previously necessitated surgical therapies, including aortic stenosis, pulmonary regurgitation and mitral regurgitation. Despite the enormous potential of these percutaneous therapies, enthusiasm needs to be balanced by an understanding of the challenges that need to be overcome before such therapies can be widely embraced. This review provides a critical assessment of the status of the major developments in percutaneous valvular intervention to date, and provides the authors' perspective on the current role and future potential of these techniques.

摘要

我们正在进入经皮治疗心脏瓣膜病的新时代。新技术和设备使得一系列以前需要外科治疗的心脏瓣膜病有可能得到治疗,包括主动脉瓣狭窄、肺动脉瓣反流和二尖瓣反流。尽管这些经皮治疗具有巨大潜力,但在这些治疗方法被广泛接受之前,需要了解必须克服的挑战,以平衡热情。本综述对迄今为止经皮瓣膜介入主要进展的现状进行了批判性评估,并阐述了作者对这些技术当前作用和未来潜力的看法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验